In this webinar, the ClinicalMind team takes at look at a novel approach to speaker training that provides a unique, fun, and meaningful experience for speakers while offering a range of downstream benefits for brands, compliance, and program management teams.

This case study discusses the use of a Delphi Panel process to facilitate expert consensus in an abbreviated time frame.

Learn more about the state of AI in medical affairs with key findings from a roundtable discussion at the recent Medical Affairs Xcellence Summit. This exclusive ClinicalMind report includes first-hand narratives, key takeaways, and strategies for successful implementation.

Plain language summaries (PLS) make research more understandable to non-experts, increase engagement in healthcare, and can be written at a reading level that accommodates a broader audience.

Explore how we identified opinion leaders who represented touchpoints along the patient journey in endocrinology.

Learn how we gather insights that determines the interconnectedness of key stakeholders.

In biopharmaceuticals, success often requires you to be the first to know and first to act in a rapidly changing environment.

Struggling to create educational content? Utilize a panel of advisors to help guide your content development plan.

Relationships with Speaker Bureau faculty are among the most important that a biopharmaceutical company nurtures.

Growing companies need an expanded network of experts. ClinicalMind’s KOL ID service can help.

How to use a strategic approach to advisory programing to develop consensus statements.

Medical and commercial leaders in pharma and biotech companies are often challenged to effectively blend cutting-edge and traditional methods for insight gathering.

Use advisory to gather insights that inform your product differentiation strategy.

ClinicalMind’s Asynchronous Advisory Suite is a game-changer for life science companies navigating the rapidly evolving and competitive therapeutic market.

Adopt strategic advisory solutions during the pre-launch lifecycle phase.

Learn how we use a strategic advisory plan for pharmaceutical product label expansions.

Phases of innovation and change are often driven by regulatory action. The Office of the Inspector General’s (OIG) 2020 special fraud alert…

Need to develop a complex, multispecialty, tiered advisory panel?

Learn how we used advisory to inform medical strategies in a rapidly changing environment.

ClinicalMind’s fresh approach to product strategy helped revitalize relationships with KOLs and HCPs, leading to changes in prescriber behavior and significant growth for the client.